Last month, our CEO Koenraad Wiedhaup spoke with co-founder and editor of MedNous, Victoria English, about Leyden Labs. They discussed the development of our platform and portfolio of prophylactic nasal sprays that should protect people from infection with respiratory viruses, such as influenza and coronaviruses.

English also discusses how Leyden Labs' intranasal products could play an important role in preventing and managing future pandemics.

To read the full article, click here.

Published in the April 2021 edition of MedNous, a publication of Evernow Publishing Ltd.